Patrick Genesis has been Appointed to Hikma’s Generics Business Development Team

Hikma Pharmaceuticals PLC , a worldwide pharmaceutical firm, has announced the appointment of Patrick Genestin as Vice President, Business Development, Generics. Mr. Genestin is a results-oriented managing director with significant financial, business and M&A experience in the pharmaceutical sector, with over 25 years of knowledge. He is stationed in the US headquarters in Berkeley Heights, New Jersey.

Mr. Genestin’s role is to oversee the management of pipelines and establish new growth prospects for Hikma Generics business, including leading licensing, M&A, proactively finding business growth possibilities, and sustaining and developing the CMO business.”Patrick is an accomplished business development leader with substantial industry experts who will be essential to as we continue to build on our excellent track record,” said Brian Hoffmann, President of Generics.

“His knowledge will be invaluable in assisting us in developing new alliances and acquiring new items that will strengthen our distinctive pipeline. He will also strive to utilize our cutting-edge Columbus, Ohio manufacturing plant by discovering new contract manufacturing options, as well as explore new growth avenues such as commercializing our portfolio outside of the United States.””I am thrilled to be joining Hikma at such an exciting moment for the firm and the Generics business,” Mr. Genestin remarked.

“Hikma Generics business has long been regarded as an industry partner of choice, thanks to its strong production capabilities and superb facilities, good quality record, and demonstrated ability to commercialize. I am very happy to work with the excellent team on this position of strength, lead our pipeline strategy, contribute to the growth and ensure the availability of important generic medicines for patients who rely on them.”